These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32998307)

  • 1. Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1).
    Ben Abderrazek R; Chammam S; Ksouri A; Perilli M; Dhaouadi S; Mdini I; Benlasfar Z; Amicosante G; Bouhaouala-Zahar B; Piccirilli A
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32998307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
    Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
    Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
    ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
    Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of purified New Delhi metallo-β-lactamase-1.
    Thomas PW; Zheng M; Wu S; Guo H; Liu D; Xu D; Fast W
    Biochemistry; 2011 Nov; 50(46):10102-13. PubMed ID: 22029287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhang YL; Yang KW; Zhou YJ; LaCuran AE; Oelschlaeger P; Crowder MW
    ChemMedChem; 2014 Nov; 9(11):2445-8. PubMed ID: 25048031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Kinetic Study of the Replacement by Site Saturation Mutagenesis of Residue 119 in NDM-1 Metallo-β-Lactamase.
    Marcoccia F; Mercuri PS; Galleni M; Celenza G; Amicosante G; Perilli M
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
    Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
    Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
    Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
    Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhai L; Jiang Y; Shi Y; Lv M; Pu YL; Cheng HL; Zhu JY; Yang KW
    Bioorg Chem; 2022 Sep; 126():105910. PubMed ID: 35653899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
    Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
    Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems.
    Ali A; Gupta D; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2019 May; 37(8):2061-2071. PubMed ID: 29749296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme.
    Ben Abderrazek R; Hamdi E; Piccirilli A; Dhaouadi S; Muyldermans S; Perilli M; Bouhaouala-Zahar B
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1
    Piccirilli A; Segatore B; Brisdelli F; Amicosante G; Perilli M
    Int J Antimicrob Agents; 2021 Jan; 57(1):106228. PubMed ID: 33246038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase.
    Chiou J; Leung TY; Chen S
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5372-8. PubMed ID: 24982075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition.
    King DT; Worrall LJ; Gruninger R; Strynadka NC
    J Am Chem Soc; 2012 Jul; 134(28):11362-5. PubMed ID: 22713171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.